Northwell Cancer Institute
Northwell Cancer Institute is the oncology division of Northwell Health, New York's largest healthcare system, operating 13 or more locations across the NY metro area to deliver comprehensive cancer care including radiation, surgery, immunotherapy, and clinical trials.
- Company typePrivate
- Founded-
- HeadquartersLake Success, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Northwell Cancer Institute does
Northwell Cancer Institute is the oncology division of Northwell Health, the largest private nonprofit healthcare system in New York. It operates 13 or more cancer care locations across the greater New York metropolitan area — including Lake Success and the R.J. Zuckerberg Cancer Center — providing comprehensive cancer services spanning screening, diagnosis, second opinions, medical oncology, surgical oncology, radiation oncology, immunotherapy, genetic counseling, survivorship, and clinical trial enrollment. The Institute operates as a hospital-anchored, integrated delivery network rather than a standalone provider, and accepts Medicare, Medicaid, and most major commercial insurance plans, generating revenue under a fee-for-service reimbursement model tied to its parent system's payer contracts.
The Institute's technology stack is among the broadest in the region and includes the Gamma Knife Icon (the only deployment on Long Island for stereotactic radiosurgery), Varian Ethos with HyperSight adaptive radiation therapy, TrueBeam, Halcyon, and Trilogy linear accelerators, proton therapy delivered through a partnership, histotripsy (non-invasive liver and kidney tumor ablation, also only on Long Island), robotic and minimally invasive surgery platforms, and CAR-T cellular therapy under FACT accreditation. It has built in-house molecular diagnostics capability via a $3.2 million laboratory supporting next-generation sequencing, and has pursued partnerships with Cold Spring Harbor Laboratory for translational research, NRG Oncology for clinical trial access, and OPKO Health/BioReference for diagnostic collaboration.
The business model is fundamentally a regional, multi-site clinical service line within a $14 billion-plus health system. Revenue derives from procedure volumes across radiation, surgery, infusion, and inpatient oncology, supplemented by ancillary diagnostics and genetic counseling. There is no indication of a direct-to-consumer product, software, or licensing revenue stream; the Institute's economic profile is that of a capital-intensive, reimbursement-dependent provider organization whose competitive position is determined by clinical capabilities, accreditation, geographic footprint, and physician talent rather than by technology IP or subscription economics.
Northwell Cancer Institute firmographics
Firmographics- Name
- Northwell Cancer Institute
- Legal name
- Northwell Health
- Website
- https://cancer.northwell.edu
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Northwell Cancer Institute is the oncology division of Northwell Health, New York's largest healthcare system, operating 13 or more locations across the NY metro area to deliver comprehensive cancer care including radiation, surgery, immunotherapy, and clinical trials.
- Ownership category
- akta.pro rank
Northwell Cancer Institute industry classification
Industry- Product category
- Oncology Services
- NAICS
- Offices of Physicians (62111), Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG), Genitourinary Oncology (HLAKAFAM), Neuro-Oncology (HLAKAFAH), Gynecologic Oncology (HLAKAFAF)
Keywords
Where Northwell Cancer Institute is headquartered
LocationHeadquarters
- HQ city
- Lake Success
- HQ country
- United States
- HQ region
- North America
Offices13 records
Markets served
Northwell Cancer Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Cancer Treatment Services: Fee-for-service healthcare delivery model for cancer treatment including chemotherapy, radiation therapy, surgery, immunotherapy, and related cancer care services. Revenue generated through insurance reimbursements, government healthcare programs (Medicare, Medicaid), and patient payments.
- Clinical Trials: Research-based revenue from clinical trials, potentially including sponsored research agreements and grant funding for innovative cancer treatments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard cancer treatment services covered by insurance |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Northwell Cancer Institute product offering
Product offeringCore offering
Northwell Cancer Institute is a comprehensive cancer care provider offering diagnosis, treatment, and supportive services across the greater New York metropolitan area. It delivers radiation therapy, chemotherapy, immunotherapy, surgical oncology, robotic surgery, genetic counseling, cancer screening, and clinical trials through a network of hospital-based cancer centers and radiation medicine facilities.
Product overview
Northwell Cancer Institute is a comprehensive cancer care provider offering a full spectrum of cancer treatment services and advanced technologies. The institute operates as a multi-location network across Long Island, New York City, Westchester, Hudson Valley, and Connecticut. Core treatment services include medical oncology, radiation therapy, surgical oncology, immunotherapy, and genetic counseling. The institute differentiates itself through advanced radiation technology platforms including Varian Ethos with HyperSight (adaptive radiation therapy), Gamma Knife Icon, TrueBeam Radiotherapy System, Trilogy System, and proton therapy. Surgical services feature robotic surgery capabilities for multiple cancer types. Patient support is provided through dedicated nurse navigators and comprehensive screening programs. The digital patient experience is delivered through the MyNorthwell portal for appointment management, test results, and provider communication.
Differentiator
Problem solved
Functional benefit
Brands
- R.J. Zuckerberg Cancer Center: Primary cancer center location at the Center for Advanced Medicine in Lake Success, NY
- Monter Cancer Center
- Katz Women's Surgical Center
- Imbert Cancer Center
Products and services
- Varian Ethos Radiation Therapy with HyperSight Advanced radiation therapy platform using real-time imaging and artificial intelligence to adapt treatment plans daily, targeting tumors precisely while avoiding healthy tissue. Available for cancer patients undergoing radiation therapy.
- Gamma Knife Icon Stereotactic radiosurgery for brain tumors, AVMs, and neurological conditions, delivering high-dose focused radiation without damaging surrounding healthy tissue. The only Gamma Knife Icon on Long Island.
- TrueBeam Radiotherapy System Hybrid linear accelerator system for pinpoint radiation therapy with advanced image guidance, delivering precise cancer treatment while protecting surrounding normal structures.
- Trilogy System Advanced radiotherapy platform combining real-time image guidance and beam delivery with breathing synchronization to precisely target tumors while minimizing radiation to healthy tissues.
- Proton Therapy External-beam radiation therapy that uses protons to treat cancer, offered in partnership in Somerset, New Jersey.
- Cancer Robotic Surgery Minimally invasive robotic-assisted surgery for prostate, kidney, colon, esophageal, liver, pancreas, cervical, lung, and thoracic cancers, offering less postoperative pain, lower infection risk, and improved recovery times.
- Immunotherapy Biologic therapy using the body's immune system to fight cancer, including checkpoint inhibitors, adoptive T cell (CAR-T) therapy, and bispecific T cell engagers (BITE).
- Chemotherapy Use of chemotherapeutic agents to kill or slow the growth of rapidly multiplying cancer cells, administered intravenously or orally.
- Genetic Counseling and Testing Comprehensive genetic testing to detect inherited factors and gene mutations that increase risk for certain cancers, including BRCA1/BRCA2 and Lynch syndrome testing, with personalized risk assessment counseling.
- Cancer Navigation Program Nurse navigator services providing personalized guidance through diagnosis, treatment, and recovery, including appointment coordination, emotional support, and connection to clinical trials.
- Cancer Screening Services Comprehensive cancer screening and prevention resources including mammograms, colonoscopies, lung cancer screening, and free screenings for uninsured and underinsured individuals.
- MyNorthwell Patient Portal Digital patient experience platform for managing appointments, accessing test results, paying bills, and communicating with providers.
Quantifiable outcome
- Complete pathological response achieved in more than 50% of triple negative breast cancer cases following initial chemotherapy
- +1 more outcomes
Companies that use Northwell Cancer Institute
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Northwell Cancer Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature10 records
Northwell Cancer Institute partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Cold Spring Harbor LaboratorycoreResearch partnership for investigator-initiated clinical trials and access to leading-edge cancer research, contributing to innovative therapies and treatment advancements.
- OPKO HealthcoreStrategic alliance for participation in clinical trials and access to novel therapies and diagnostic technologies in cancer care.
- NRG OncologycorePartnership in NRG Oncology clinical trials, providing patients access to national cancer research studies and collaborative treatment approaches.
- New York State Department of Health Cancer Services ProgramcorePartnership to provide free cancer screening services for uninsured and underinsured individuals at multiple Northwell locations including LIJ, Queens, Staten Island, Suffolk, Westchester, and Hudson Valley.
- Connecticut Early Detection and Prevention ProgramminorPartnership to provide free cancer screenings in Danbury and Norwalk, Connecticut for eligible individuals.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Northwell Cancer Institute competitors and assessment
Company assessmentDirect peers
- City of Hope: Large NCI-designated comprehensive cancer center operating multi-site cancer programs across California, Arizona, and Illinois. Comparable in being a high-volume, multi-modality community-integrated cancer delivery network with strong research and cellular therapy programs.
- Roswell Park Comprehensive Cancer Center: Buffalo-based standalone NCI-designated comprehensive cancer center. Comparable in being a high-volume, multi-modality cancer program with research depth, though operating in a different upstate NY geography.
- Memorial Sloan Kettering Cancer Center: The dominant standalone cancer center in the NYC metro. Comparable in offering comprehensive medical, surgical, and radiation oncology across multiple sites, and competes directly for tertiary and complex cancer referrals that NCI also targets.
- NYU Langone Health Perlmutter Cancer Center: NYC-based NCI-designated comprehensive cancer center offering medical oncology, radiation, surgery, CAR-T, and clinical trials across Manhattan and Brooklyn. Direct competitor for the same patient population NCI serves.
- Mount Sinai Tisch Cancer Institute: NYC-based comprehensive cancer program offering the same modalities (radiation, surgery, immunotherapy, CAR-T, clinical trials). NCI actively hired from Mount Sinai (Kai Tsao), evidencing direct head-to-head competition for talent and patients.
- Montefiore Einstein Cancer Center: Bronx-based NCI-designated cancer center operating as a multi-site program in the NYC metro. Overlaps with NCI on radiation, medical oncology, and surgical oncology in Westchester and the Bronx catchment.
- NewYork-Presbyterian/Columbia Herbert Irving Comprehensive Cancer Center: NYC-based NCI-designated cancer program at Columbia. Competes for complex cases, surgical oncology, and radiation therapy referrals in the same metro as Northwell.
Regional players
- Hackensack Meridian Health Cancer Care: New Jersey's largest cancer program and John Theurer Cancer Center partner. Comparable service breadth (radiation, surgical, cellular therapy) but primarily serves NJ patients, overlapping with NCI's NJ proton therapy partnership catchment.
- Penn Medicine Abramson Cancer Center: Philadelphia-based NCI-designated comprehensive cancer center with comparable radiation, surgical, CAR-T, and clinical trial portfolio. Regional rather than direct competitor given geography, but comparable in scale and academic depth.
Broad incumbents
- Cancer Treatment Centers of America / City of Hope Atlanta: Now part of City of Hope, this network operates destination cancer hospitals with comprehensive radiation, surgical, and medical oncology offerings—comparable in service model to Northwell Cancer Institute's multi-site delivery.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Northwell Cancer Institute social profiles
Digital presenceNorthwell Cancer Institute compliance and trust
Trust signalCompliance6 records
Northwell Cancer Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Northwell Cancer Institute leadership team
Management profileNumber of profiles
Profiles3 records
Northwell Cancer Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Northwell Cancer Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Northwell Cancer Institute
What does Northwell Cancer Institute do?
Northwell Cancer Institute is a comprehensive cancer care provider offering diagnosis, treatment, and supportive services across the greater New York metropolitan area. It delivers radiation therapy, chemotherapy, immunotherapy, surgical oncology, robotic surgery, genetic counseling, cancer screening, and clinical trials through a network of hospital-based cancer centers and radiation medicine facilities.
Is Northwell Cancer Institute a public or private company?
Northwell Cancer Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Northwell Cancer Institute founded?
Northwell Cancer Institute was founded in -1. It employs 11 to 50 people.
Where is Northwell Cancer Institute based?
Northwell Cancer Institute is headquartered in Lake Success, United States, in the North America region.
How does Northwell Cancer Institute make money?
Two revenue lines are on record. Cancer Treatment Services are the primary driver. The others are clinical Trials.
Who are Northwell Cancer Institute's main competitors?
Direct peers on record are City of Hope, Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, NYU Langone Health Perlmutter Cancer Center, Mount Sinai Tisch Cancer Institute, Montefiore Einstein Cancer Center and NewYork-Presbyterian/Columbia Herbert Irving Comprehensive Cancer Center. Regional players are Hackensack Meridian Health Cancer Care and Penn Medicine Abramson Cancer Center. Cancer Treatment Centers of America / City of Hope Atlanta is listed as a broad incumbent.
Does Northwell Cancer Institute have an API?
No public API is recorded for Northwell Cancer Institute.
What industry is Northwell Cancer Institute in?
Northwell Cancer Institute's product category is Oncology Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 62111 and its SIC code is 8093.